Mark Foletta
2019
In 2019, Mark Foletta earned a total compensation of $981.1K as Executive Vice President and Chief Financial Officer at Forte Biosciences, a 21% decrease compared to previous year.
Compensation breakdown
| Option Awards | $592,443 |
|---|---|
| Salary | $388,308 |
| Other | $360 |
| Total | $981,111 |
Foletta received $592.4K in option awards, accounting for 60% of the total pay in 2019.
Foletta also received $388.3K in salary and $360 in other compensation.
Rankings
In 2019, Mark Foletta's compensation ranked 9,358th out of 13,971 executives tracked by ExecPay. In other words, Foletta earned more than 33.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,358 out of 13,971 | 33rd |
Division Manufacturing | 3,757 out of 5,701 | 34th |
Major group Chemicals And Allied Products | 1,429 out of 2,200 | 35th |
Industry group Drugs | 1,218 out of 1,886 | 35th |
Industry Pharmaceutical Preparations | 905 out of 1,398 | 35th |
Source: SEC filing on April 30, 2021.
Foletta's colleagues
We found two more compensation records of executives who worked with Mark Foletta at Forte Biosciences in 2019.